| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6020112 | Journal of Neuroimmunology | 2015 | 6 Pages |
Abstract
Our results demonstrate that laquinimod suppresses inflammation through down-regulation of inflammatory cytokines and arrest of leukocyte extravasation and thereby could attenuate disease activity in RRMS patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
R. Zilkha-Falb, M. Gurevich, L. Hayardeny, A. Achiron,